UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | G | H | J | L | M | N | P | R | V
Number of items: 19.

B

Beyaert, R; Vanhaesebroeck, B; Suffys, P; Van Roy, F; Fiers, W; (1989) Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc Natl Acad Sci U S A , 86 (23) pp. 9494-9498.

C

CALVERT, AH; NEWELL, DR; GUMBRELL, LA; OREILLY, S; BURNELL, M; BOXALL, FE; SIDDIK, ZH; (1989) CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION. J CLIN ONCOL , 7 (11) 1748 - 1756.

Calvert, AH; (1989) Introduction: a history of the progress of anticancer chemotherapy. Cancer Surv , 8 (3) pp. 493-509.

D

Dowsett, M; Cunningham, DC; Stein, RC; Evans, S; Dehennin, L; Hedley, A; Coombes, RC; (1989) Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. In: (pp. pp. 1306-1312).

G

GORE, ME; FRYATT, I; WILTSHAW, E; DAWSON, T; ROBINSON, BA; CALVERT, AH; (1989) CISPLATIN CARBOPLATIN CROSS-RESISTANCE IN OVARIAN-CANCER. BRIT J CANCER , 60 (5) 767 - 769.

GRAHAM, MA; NEWELL, DR; CALVERT, AH; (1989) DETERMINATION OF THE ANTHRAPYRAZOLE ANTICANCER DRUG CI-941 IN PLASMA AND URINE BY SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY. J CHROMATOGR-BIOMED , 491 (1) 253 - 261.

GRAHAM, MA; NEWELL, DR; FOSTER, BJ; CALVERT, AH; (1989) THE PHARMACOKINETICS AND TOXICITY OF THE ANTHRAPYRAZOLE ANTI-CANCER DRUG CI-941 IN THE MOUSE - A GUIDE FOR RATIONAL DOSE ESCALATION IN PATIENTS. CANCER CHEMOTH PHARM , 23 (1) 8 - 14.

H

HARRAP, KR; JACKMAN, AL; NEWELL, DR; TAYLOR, GA; HUGHES, LR; CALVERT, AH; (1989) THYMIDYLATE SYNTHASE - A TARGET FOR ANTICANCER DRUG DESIGN. ADVANCES IN ENZYME REGULATION, VOL 29 , 29 161 - 179.

J

JONES, TR; BETTERIDGE, RF; NEIDLE, S; JACKMAN, AL; CALVERT, AH; (1989) QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - COMPUTER MODELING OF THE N-10 SUBSTITUENT. ANTI-CANCER DRUG DES , 3 (4) 243 - 248.

JONES, TR; THORNTON, TJ; FLINN, A; JACKMAN, AL; NEWELL, DR; CALVERT, AH; (1989) QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - 2-DESAMINO DERIVATIVES WITH ENHANCED SOLUBILITY AND POTENCY. J MED CHEM , 32 (4) 847 - 852.

JUDSON, IR; CALVERT, AH; RUTTY, CJ; ABEL, G; GUMBRELL, LA; GRAHAM, MA; EVANS, BD; (1989) PHASE-I TRIAL AND PHARMACOKINETICS OF TRIMELAMOL (N-2,N-4,N-6-TRIHYDROXYMETHYL-N-2,N-4,N-6-TRIMETHYLMELAMINE). CANCER RES , 49 (19) 5475 - 5479.

L

Lee, M; Shea, RG; Hartley, JA; Lown, JW; Kissinger, K; Dabrowiak, JC; Vesnaver, G; (1989) Molecular recognition between oligopeptides and nucleic acids. Sequence specific binding of (4S)-(+)- and (4R)-(-)-dihydrokikumycin B to DNA deduced from 1H NMR, footprinting studies and thermodynamic data. J Mol Recognit , 2 (1) pp. 6-17. 10.1002/jmr.300020103.

M

MARSHAM, PR; CHAMBERS, P; HAYTER, AJ; HUGHES, LR; JACKMAN, AL; OCONNOR, BM; BISHOP, JAM; (1989) QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - NITROGEN, OXYGEN, SULFUR, AND CHLORINE SUBSTITUENTS IN THE C2 POSITION. J MED CHEM , 32 (3) 569 - 575.

N

NEWELL, DR; EELES, RA; GUMBRELL, LA; BOXALL, FE; HORWICH, A; CALVERT, AH; (1989) CARBOPLATIN AND ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH TESTICULAR TERATOMA. CANCER CHEMOTH PHARM , 23 (6) 367 - 372.

P

PAN, LX; BEVERLEY, PCL; BOBROW, LG; SWALLOW, DM; ISAACSON, PG; (1989) PRODUCTION OF MONOCLONAL-ANTIBODIES TO LACTATE-DEHYDROGENASE (LDH) ISOENZYMES FOR IMMUNOHISTOCHEMICAL STUDY ON FIXED TISSUE SECTION. HISTOCHEM J , 21 (11) 638 - 644.

PEDLEY, RB; BODEN, JA; BODEN, RW; GREEN, A; BOXER, GM; BAGSHAWE, KD; (1989) THE EFFECT OF SERUM CEA ON THE DISTRIBUTION AND CLEARANCE OF ANTI-CEA ANTIBODY IN A PANCREATIC TUMOR XENOGRAFT MODEL. BRIT J CANCER , 60 (4) 549 - 554.

PEDLEY, RB; DALE, R; BODEN, JA; BEGENT, RHJ; KEEP, PA; GREEN, AJ; (1989) THE EFFECT OF 2ND ANTIBODY CLEARANCE ON THE DISTRIBUTION AND DOSIMETRY OF RADIOLABELED ANTI-CEA ANTIBODY IN A HUMAN COLONIC TUMOR XENOGRAFT MODEL. INT J CANCER , 43 (4) 713 - 718.

R

Reszka, K; Hartley, JA; Kolodziejczyk, P; Lown, JW; (1989) Interaction of the peroxidase-derived metabolite of mitoxantrone with nucleic acids. Evidence for covalent binding of 14C-labeled drug. Biochem Pharmacol , 38 (23) pp. 4253-4260.

V

Vanhaesebroeck, B; Grooten, J; Fiers, W; (1989) An ongoing in vivo immune response affects the abundancy and differentiation of lymphokine-activated killer cell precursors, but does not influence their broad spectrum target reactivity. J Immunol , 143 (4) pp. 1396-1402.

This list was generated on Sun Dec 11 03:17:34 2016 GMT.